04Sep 2023
Outcomes of repeat transcatheter aortic valve replacement with balloon-expandable valves

Outcomes of repeat transcatheter aortic valve replacement with balloon-expandable valves

A recent study examined the safety and effectiveness of redo-transcatheter aortic valve replacement (TAVR) using balloon-expandable valves. The research analyzed data from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry, encompassing patients from 2011 to 2022. The results indicated that redo-TAVR had low procedural complications, similar to native-TAVR. There was no significant difference in mortality or stroke rates at 30 days or 1 year. Redo-TAVR effectively reduced aortic valve gradients and had comparable aortic regurgitation rates. The study suggests that redo-TAVR is a viable option for certain patients with failed TAVR.

  • #cardiology

Like

Save

Share